Joint Programming Initiative on Antimicrobial Resistance
 

JPIAMR Strategic Working Groups 2017 – 2020

The Joint Programming Initiative on Antimicrobial Resistance, JPIAMR, main ambition is to reduce AMR by supporting scientific activities at international level. This will offer evidence-based solutions at policy, public health and veterinarian/agricultural levels; by alignment of national research programmes, mobilisation of resources and incentivizing collaboration among the scientific community.

The JPIAMR Strategic Research Agenda provides a framework to support world-class research on AMR to articulate the joint actions supported by a Strategic Plan 2018-2020.

In order to organise the portfolio of joint activities the JPIAMR Management Board has set 7 strategic Working Groups. The mandate of the WG is to serve as think-tanks/brainstorming of the WGs action plans, to provide leader and to approve the activities.

The JPIAMR MB Strategic Working Groups objectives and main actions:

WG1: Evaluation (Chair: Spain)

  • Develop a comprehensive framework for Evaluation (expost), Monitoring, Mapping and Databases activities
  • Monitor IPR and Open Access implementation
  • Monitoring & ex-post evaluation of funded projects
  • Define information sources including: questionnaires to evaluate impact on: research policy, research excellence, AMR relevant policies, health care & industry

WG2: Governance (Chair: Spain)

  • To develop a long term strategic plan 2020-2025:
    • Development of catalogue of strategic actions to be discussed at roadmap workshops on SRA pillars + funding instruments + long-term financial commitment.
  • To explore possible scenarios for long-term sustainability by Member Countries
  • To develop a business plan for the sustained JPIAMR management and implementation of long-term activities
    • To update the governance structure
    • To develop a MoU

WG3: Globalisation (Chair: Germany)

  • Extension of the JPI into a global level
  • Increasing membership to countries currently not participating, especially in Europe and key countries in other continents
    • Inventory of new potential member countries and contact points.
    • Identification of existing programmes, mapping and analysis of present participation and barriers to participation through questionnaires.
    • Explore different funding modes and develop new activities
    • Development of materials to inform about JPIAMR benefits and the range of suitable opportunities of collaborations to the scientific community and policy makers
    • Introducing measures in order to increase the participation of under-represented countries in call activities.
    • Development of new instrument/pilot programme tailored to the needs and capacity of the target countries
  • Update the membership policy
  • Promote JPIAMR in the key international platforms

WG4: Policy Alignment (Chair: Sweden)

  • Aim for a better integration of JPIAMR efforts and SRIA with national strategies by engaging the national policy makers across different agencies seeking a One Health approach.
    • Alignment of member countries National inter-sectorial policies and programmes
    • Development and implementation of existing and new action plans for further coordination of national (research) strategies and JPIAMR research agendas/plans.
  • To build strong ties with other international initiatives or partners at European and global level and strengthen the existing collaborations (including WHO, Transatlantic Task Force on AMR (TATFAR), G7, ECDC, DG Santé Joint Action) and integrating this with the relations with national public health, agriculture, and environmental authorities at the supranational level
  • To develop an international AMR Funder’s forum with the key funding agencies (HIRO group, European Commission, Fleming Fund, AMR Global Fund (potential), (potential), DNDi, industry funding initiatives, where sharing background information and future strategies between initiatives will provided the foundation for strategic partnerships in funding AMR research.
  • To enhance communication between AMR health policy and AMR research policy
  • To influence international policy on AMR research

WG5: Research Alignment (Chair: The Netherlands)

  • To update and extend the SRA into a joint Strategic Research an Innovation Agenda (SRiA) by adding the translational dimension strengthening its One Health Approach and addressing AMR as a global societal challenge
  • To provide an implementation roadmap of the SRiA

WG6: Virtual institute and research infrastructures (Chair: Canada)

  • To create a structure (an JPI AMR Virtual Institute – VI) linking existing AMR infrastructures
    • To define a concept paper model
    • To identify funding sources
    • To set it up
  • To build AMR research capacity globally through a VI
  • To develop a VI research program aligned with JPIAMR Strategic Research Agenda
  • To showcase the VI through a web portal
  • To showcase the AMR related research infrastructures through a web portal
  • To support enabling activities and infrastructures concerning sharing and re-using data, strains and samples important for AMR research.

WG7: Industry relations (Chair: UK)

  • To strengthen alignment with industry and IMI by mapping and presenting existing initiatives, creating and maintaining a dialogue with all relevant national and international policy makers, research performers, and stakeholders, and provide tools and an arena for the support of further alignment
  • To develop guidelines with recommendations on how academia and industry can collaborate
  • To develop a technical platform/database to be implemented on the JPIAMR website:
    • AMR projects data collection
    • AMR infrastructures data collection
    • AMR industrial data collection